These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1531540)

  • 21. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
    Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human platelet basic protein/connective tissue activating peptide-III maps in a gene cluster on chromosome 4q12-q13 along with other genes of the beta-thromboglobulin superfamily.
    Wenger RH; Hameister H; Clemetson KJ
    Hum Genet; 1991 Jul; 87(3):367-8. PubMed ID: 1830861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
    J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification.
    Holt JC; Niewiarowski S
    Methods Enzymol; 1989; 169():224-33. PubMed ID: 2523998
    [No Abstract]   [Full Text] [Related]  

  • 26. Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes.
    Holt JC; Rabellino EM; Gewirtz AM; Gunkel LM; Rucinski B; Niewiarowski S
    Exp Hematol; 1988 May; 16(4):302-6. PubMed ID: 2966071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human platelet basic protein. Its relation to low affinity platelet factor 4 and beta-thromboglobulin.
    Varma KG; Niewiarowski S; Holt JC; Rucinski B; Paul D
    Biochim Biophys Acta; 1982 Feb; 701(1):7-11. PubMed ID: 6173075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
    Schröder JM; Persoon NL; Christophers E
    J Exp Med; 1990 Apr; 171(4):1091-100. PubMed ID: 2182761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
    Power CA; Proudfoot AE; Magnenat E; Bacon KB; Wells TN
    Eur J Biochem; 1994 Apr; 221(2):713-9. PubMed ID: 7513641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin.
    Van Damme J; Van Beeumen J; Conings R; Decock B; Billiau A
    Eur J Biochem; 1989 May; 181(2):337-44. PubMed ID: 2523801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and separation of secreted platelet proteins by isoelectric focusing. Evidence that low-affinity platelet factor 4 is converted to beta-thromboglobulin by limited proteolysis.
    Niewiarowski S; Walz DA; James P; Rucinski B; Kueppers F
    Blood; 1980 Mar; 55(3):453-6. PubMed ID: 6153537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity.
    Brandt E; Petersen F; Flad HD
    Mol Immunol; 1993 Aug; 30(11):979-91. PubMed ID: 7688853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4.
    Schröder JM; Sticherling M; Persoon NL; Christophers E
    Biochem Biophys Res Commun; 1990 Oct; 172(2):898-904. PubMed ID: 2241978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8.
    Sticherling M; Schröder JM; Christophers E
    J Immunol; 1989 Sep; 143(5):1628-34. PubMed ID: 2668411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
    Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
    Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
    Schwartzkopff F; Brandt E; Petersen F; Flad HD; Bock L; Ludwig A
    J Interferon Cytokine Res; 2002 Feb; 22(2):257-67. PubMed ID: 11911809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
    Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
    Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
    J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein S degradation in vitro by neutrophil elastase.
    Eckle I; Seitz R; Egbring R; Kolb G; Havemann K
    Scand J Clin Lab Invest; 1993 May; 53(3):281-8. PubMed ID: 8316756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.